Company Search:
Advanced Search
Sponsored Links
Endocyte, Inc. Company Snapshot
Endocyte, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Endocyte with three other companies in this sector in the United States: Acadia Pharmaceuticals, Inc. (2015 sales of $61,000.00 of which 100% was Molecular Drugs), RegeneRx Biopharmaceuticals, Inc. ($60,612.00 ), and Cocrystal Pharma Inc ($78,000.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Endocyte, Inc.
  Stock Performance Chart for Endocyte, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 2.24
(Figures in U.S. Dollars)
1 Week -12.8%   13 Weeks -17.6%  
4 Weeks -25.1%   52 Weeks -37.4%  
Endocyte, Inc. Key Data:
  Ticker: ECYT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 70,000
(Year Ending Jan 2016).
Employees: 78
  Currency: U.S. Dollars Market Cap: 94,680,475
  Fiscal Yr Ends: December Shares Outstanding: 42,268,069
  Share Type: Common Closely Held Shares: 1,105,529
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.